GLP-1 side effects: what is common, what is rare, what to do

Every medication has side effects. GLP-1 therapy is no exception. The difference between a frightening leaflet and a manageable treatment is usually knowing which side effects are common and minor, which are rare but serious, and what to do about each.

This is the honest picture, based on the clinical evidence and what patients actually experience.

The common side effects

The following effects are reported by roughly one in five to one in three patients at some point during treatment. They are not pleasant but they are usually manageable, and they almost always settle within a few weeks of starting or after a dose increase.

Nausea is the most common, affecting around 30 to 40 percent of patients in the first few weeks. It is usually mild, often described as a slight queasiness rather than the sickening nausea of a stomach bug. It is most likely in the 24 to 48 hours after each injection and tends to fade as the body adjusts to each dose level. By week six on a stable dose, most patients no longer experience it.

Reduced appetite is technically the intended effect, not a side effect, but it can feel unusual at first. Some patients describe a strange sensation of being full without having eaten much, or of having to remind themselves to eat at meal times. This is the medication working. The aim is to use it sensibly, not to skip meals entirely.

Constipation affects around one in five patients. The slowed digestive transit that produces fullness also slows everything else. The treatment is usually straightforward: more water, more fibre, and a gentle laxative if needed. Most patients find this manageable once they adapt their eating.

Diarrhoea is less common than constipation but still reported by some patients, particularly in the first few weeks. It usually settles without intervention.

Heartburn or reflux can occur because food is sitting in the stomach longer. Not lying down for an hour after eating, eating smaller meals, and avoiding very fatty foods generally resolves this.

Fatigue in the first week or two is common, particularly if you are eating substantially less than usual. This is your body adjusting to reduced caloric intake. It typically resolves within ten days as your energy adapts.

Injection site reactions are usually a small red dot, sometimes with mild itching, lasting a few hours. These are normal. Rotating injection sites between abdomen, thigh, and upper arm helps prevent any cumulative irritation.

How to manage them

Most common side effects respond to a few practical changes. None of these require medical intervention.

Eat slowly and stop sooner than you normally would. Your stomach is emptying more slowly. Eating at your old pace will leave you uncomfortably full and possibly nauseous. The new rule of thumb is to stop at 80 percent full, then wait twenty minutes. You will not be hungry again.

Drink water throughout the day. Two to three litres reduces both nausea and constipation. Set reminders if you find yourself forgetting, because GLP-1 therapy dulls thirst signals along with hunger.

Get protein at every meal. Smaller portions plus the same old food choices means you will run low on protein, which makes fatigue and muscle loss worse. Aim for 25 to 35 grams per meal: eggs, yoghurt, chicken, fish, lentils, or a protein shake if cooking is too much effort.

Time your injection for a calm period. Most patients pick a weekend evening, so any mild side effects fall during downtime rather than during a busy workday.

Avoid very fatty or fried foods for the first day or two after injection. Fat slows stomach emptying further, and combined with the medication this can cause real discomfort. Lighter meals are better tolerated.

Move gently. A short walk after meals helps digestion. Strenuous exercise on injection day is not necessary and can compound nausea. Most patients find their normal exercise routine works perfectly well from day two onwards.

Less common effects

The following effects are reported by less than one in ten patients but are worth knowing about so you recognise them if they appear.

Hair shedding is occasionally reported, usually three to four months in. It is almost always temporary and tied to the rapid weight loss rather than the medication directly. Adequate protein intake, biotin if you want it, and patience usually resolve it within a few months.

Altered taste sometimes occurs. Foods that used to be appealing taste different. Sweet foods often become less appealing, which most patients welcome. Occasionally savoury foods seem off-balance for a few weeks. Taste usually normalises as the body adjusts.

Dizziness on standing can happen if you are not eating or drinking enough. This is a signal to increase fluids and ensure regular meals, even if not hungry.

Mood changes are reported by a small subset of patients. Some find their mood improves as weight loss progresses. A few report low mood, particularly if food has been a significant emotional anchor. If you notice this, mention it to your coach early. It usually settles but is worth flagging.

Mild palpitations are occasionally reported. They are usually benign and tied to caffeine sensitivity changing as eating patterns change. If they persist or are uncomfortable, your doctor should review.

Rare but serious effects

These are uncommon but warrant immediate medical attention if they occur.

Pancreatitis is the most discussed serious risk with GLP-1 therapy. The actual incidence is low, but the symptoms are distinct enough to recognise: severe upper abdominal pain that does not settle within a few hours, often radiating to the back, frequently with nausea and vomiting. This requires emergency assessment. Your doctor screens for risk factors before prescribing.

Gallbladder problems are more common in patients losing weight rapidly through any means, including GLP-1 therapy. Symptoms include pain in the upper right abdomen, often after fatty meals, sometimes with nausea and a feverish feeling. Worth reporting promptly but rarely an emergency.

Severe allergic reaction to any medication is rare but possible. Symptoms include widespread hives, swelling of the face or throat, difficulty breathing, or rapid heart rate. This requires emergency attention.

Thyroid concerns are theoretical based on animal studies. The risk has not been confirmed in humans, but as a precaution, GLP-1 therapy is not prescribed to patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2.

Kidney problems can occur if severe vomiting or diarrhoea leads to dehydration. The kidneys themselves are not damaged by the medication, but inadequate fluid intake during gastrointestinal upset can cause acute kidney injury. Maintaining hydration prevents this.

When to call your doctor

Use this list as a quick reference.

• Severe abdominal pain that does not settle
• Persistent vomiting beyond 24 to 48 hours
• Yellow tinge to skin or eyes
• Severe headache with vision changes
• Signs of allergic reaction (widespread rash, facial swelling, breathing difficulty)
• Unusual bruising or bleeding
• Significant changes in mood lasting more than a few days
• Anything that worries you, even if not on this list

Most of these are unlikely. The reason to know them is so you can act quickly if they happen, rather than wondering whether what you are feeling is normal.

Are the side effects worth it

This is the question worth sitting with before starting. The answer is genuinely individual.

For patients with significant obesity, particularly with weight-related health conditions, the side effects are usually a price worth paying for the clinical benefit. Reducing the risk of type 2 diabetes complications, improving sleep apnoea, reducing joint pain, and improving cardiovascular markers are meaningful health gains. A few weeks of mild nausea in exchange for those outcomes is generally a good trade.

For patients who could lose the same weight through lifestyle alone, the calculation is different. The medication is not free of cost, financial or physical, and it should be reserved for situations where the clinical benefit justifies the intervention.

The patients who do best are those who go in with realistic expectations: yes there will be some side effects, no they are not usually severe, yes they settle within a few weeks, and yes the benefits over twelve months tend to substantially outweigh the discomfort. Your doctor and coach are there to help you navigate the bumpy bits.

The bottom line

GLP-1 therapy is well-tolerated by most patients. Common side effects are mild, predictable, and time-limited. Serious side effects are rare. Knowing what to expect, knowing how to manage it, and knowing when to seek help is the difference between a successful treatment and an anxious one.